002940.SZ
昂利康
SZSE · Healthcare · C 制造业 · CN
CNY 25.29
−4.17%Year over year
Reported trailing growth
- Revenue
- -3.8%
- EBITDA
- —
- EBIT
- +33.6%
- EPS
- +87.2%
- Free cash flow
- +168.0%
- Operating cash flow
- +63.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.2%
- EBITDA
- +7.5%
- EBIT
- +7.1%
- Net income
- -0.5%
- EPS
- -1.1%
- Free cash flow
- +18.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026